灵康药业 (603669)
Lionco Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data available
Company NameLingkang Pharmaceutical Group Co., Ltd.
Listing Date2015-05-28
Issue Price11.7RMB
Registered Capital72124.475510k RMB
Legal RepresentativeTao Lingping
Registered AddressNo. 20, National Highway 349 (Jieba Township Section), Naidong District, Shannan City, Tibet Autonomous Region
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of chemical prescription drugs.
Company ProfileLingkang Pharmaceutical Group Co., Ltd. was founded in 2003 and is an innovative group enterprise integrating pharmaceutical R&D, production, and sales.
Lingkang Pharmaceutical Group Co., Ltd. holds 180 approvals and has eight workshops: general powder injection workshop, cephalosporin powder injection workshop, cephalosporin lyophilized powder injection workshop, general lyophilized powder injection workshop, small-volume injection workshop, oral solid preparation workshop, cephalosporin API workshop, and general API workshop, all of which have passed national GMP certification. Among them, the technical level and production capacity of the lyophilization production line have reached internationally advanced and domestically leading standards, and the market share of medical nutrition products holds a leading position in the industry.
Stock Details
1. Key Indicators
- Total Shares(W): 72124.48
- Circulating A-Shares(W): 72124.48
- Earnings Per Share(RMB): -0.0478
- Net Assets Per Share(RMB): 0.9356
- Operating Revenue(W RMB): 28186.07
- Total Profit(W RMB): -3450.28
- **Net Profit Attributable to Parent(W RMB) **: -3450.31
- Net Profit Growth Rate(%): 26.42
- Weighted Return on Equity(%): -4.5900
- Operating Cash Flow Per Share(RMB): -0.1640
- Undistributed Profit Per Share(RMB): -0.4731
- Capital Reserve Per Share(RMB): 0.3642
2. Main Business
The main business covers:
- Research, development, production, and sales of chemical prescription drugs
3. Company Basic Information
- Company Name: Lingkang Pharmaceutical Group Co., Ltd.
- Listing Date: 2015-05-28
- Industry: Pharmaceutical Manufacturing
- Address: First Floor, Building 2, Naidong County Commercial and Residential Building, 68 Naidong Road, Zedang Town, Shannan City, Tibet Autonomous Region
- Website: https://www.lingkang.com.cn
- Company Profile: The company's predecessor was Hainan Lingkang Pharmaceutical Co., Ltd., established on December 24, 2003. In October 2012, Lingkang Limited was transformed into Hainan Lingkang Pharmaceutical Group Co., Ltd. based on the net assets audited by Tianjian Firm as of July 31, 2012, converted into 19,500 million shares. All assets, liabilities, business, and personnel of Lingkang Limited were inherited by the transformed joint-stock company. On October 16, 2012, the Hainan Administration for Industry and Commerce issued the "Business License". On December 18, 2013, the company relocated to Shannan, Tibet and changed its name to "Tibet Lingkang Pharmaceutical Group Co., Ltd.". On March 12, 2014, the company was renamed "Lingkang Pharmaceutical Group Co., Ltd.".
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Lingkang Holding Group Co., Ltd. | General Legal Person | 33965.28 | 47.09 |
| 2 | Shanghai Danyin Investment Management Center (Limited Partnership) - Danyin Preferred No. 1 Private Securities Investment Fund | Private Securities Investment Fund | 253.30 | 0.35 |
| 3 | Beijing Great Times Private Fund Management Co., Ltd. - Great Times Mama 77 Private Securities Investment Fund | Private Securities Investment Fund | 196.40 | 0.27 |
5. Concept Sectors
- Convertible Bonds
- Private Hospitals
- CXO Concept
- Innovative Drugs
- Consecutive Losses
- New Private Placements
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information